# Vericel Corporation – FDA Inspection, Jun 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/vericel-corporation/02e881c9-9b82-410c-b598-43e33c6e9d99
Source feed: FDA_Inspections

> FDA inspection 1322008 of Vericel Corporation, June 12, 2026. 4 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1322008
- Company Name: Vericel Corporation
- Inspection Date: 2026-06-12
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: New England District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1249999 - 2024-09-25](https://www.keypedia.com/records/fda_inspections/vericel-corporation/14fd491e-b3d9-4240-a85a-736a89e99616)
- [FDA Inspection 1210597 - 2023-07-21](https://www.keypedia.com/records/fda_inspections/vericel-corporation/b6697f78-5c18-4b52-b12d-acb5f892368c)
- FDA Inspection 1006746 - 2016-05-27
- FDA Inspection 870615 - 2014-03-19
- FDA Inspection 747422 - 2011-09-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/richard-l-bartlett/602337b9-ac77-41bb-a254-71a9d345335b)

Company: https://www.keypedia.com/companies/vericel-corporation/1955c523-5115-491b-a705-2c526deb9ff6

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144